Prime Minister Narendra Modi will be visiting Pune's Serum Institute of India (SII) on November 28 to review the work on the development of 'Covishield' vaccine which is being developed by British-Swedish pharmaceutical giant AstraZeneca in collaboration with UK's Oxford University.
